CEACAM5 and colorectal carcinoma: Most CRC patients (93.71%) had CRC differentiation grade I‐II, 164 (57.34%) patients were diagnosed with TNM stage I‐II and 172 (60.14%) patients had serum CEA <5 ng/ml.